SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS) revenue breakdown overview

SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS) revenue for the last year amounted to 800.00 k CHF, the most of which — 103.41 M CHF — came from its highest performing source at the moment, Specialty Niche Products, the year earlier bringing 7.47 M CHF. The greatest contribution to the revenue figure was made by North America — last year it brought SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS) 98.09 M CHF.